Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-05-04 @ 1:01 PM
Study NCT ID:
NCT05036005
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2021-08-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
Sponsor:
Organization: